Administration of IFNA at 8 h post infection resulted in a significant reduction in influenza virus kinetics compared to addition at 24 h (p = 0.047) or 48 h (p = 0.0154) post-infection (Fig. 1). The gene discussed is IFNA2; the disease is infection.